Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-011815
Filing Date
2025-05-20
Accepted
2025-05-20 17:29:51
Documents
59
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 1062557
2 EX-31.1 ex31-1.htm EX-31.1 7447
3 EX-32.1 ex32-1.htm EX-32.1 4229
  Complete submission text file 0001641172-25-011815.txt   5408632

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE sigy-20250331.xsd EX-101.SCH 36441
5 XBRL CALCULATION FILE sigy-20250331_cal.xml EX-101.CAL 43900
6 XBRL DEFINITION FILE sigy-20250331_def.xml EX-101.DEF 141521
7 XBRL LABEL FILE sigy-20250331_lab.xml EX-101.LAB 340353
8 XBRL PRESENTATION FILE sigy-20250331_pre.xml EX-101.PRE 272430
61 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 900654
Mailing Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212
Business Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212 619-368-2000
Sigyn Therapeutics, Inc. (Filer) CIK: 0001642159 (see all company filings)

EIN.: 472573116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55575 | Film No.: 25970157
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)